If you think there has been an overdose, call your poison control center or get medical care right away. Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:Gavreto (pralsetinib) is an oral selective RET kinase inhibitor for the...Onureg (azacitidine) is a nucleoside metabolic inhibitor indicated for the...Qdolo (tramadol hydrochloride) is an opioid agonist indicated in adults for ...Xaracoll (bupivacaine hydrochloride) is a fully bioresorbable collagen implant...The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. © 2005-2020 Healthline Media a Red Ventures Company. Lupin Pharmaceuticals Inc.’s branded pharmaceuticals division, is the provider of products designed to help prevent and manage women’s health conditions with serious health consequences.June 05, 2020 -- Apotex is expanding the previously announced Retail Level recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg that was initiated on May 29, 2020 to Consumer Level.Apotex was notified by the U.S. Food and Drug Administration (US FDA) that one lot of Metformin Hydrochloride Extended-Release Tablets, USP was tested and showed results for N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit (ADI) and recommended recall of the one tested lot. The FDA Alert(s) below may be specifically about metformin or relate to a group or class of drugs which include metformin.MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. Live calls are received Monday-Friday, 9:00 am to 5:00 pm Eastern Time with voicemail available 24 hours/day, 7 days/week or by email at Patients wishing to return product may contact Teva’s product recall processor to obtain instructions and a return kit for returning their medication:Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.Patient safety and product quality are critical to Teva. Useful tip: Search for the imprint first, then refine by color and shape if you have too many results.


Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. More than 18 million Americans take it daily to control their blood sugar.

Together, all Lupin-owned entities combine to make up the 8th largest generic pharmaceutical company in the world by revenue size.Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality medications across many treatment areas. Tel: (855) 532-1856.Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at (855) 532-1856 Monday – Friday 09:00 am to 05:00 pm EST. Tel: Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.Lupin Pharmaceuticals, Inc. is the U.S. based wholly-owned subsidiary of Lupin Limited and is the 3rd largest pharmaceutical company in the U.S. based on total prescriptions. Call your doctor or get medical

The affected Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, being recalled are described as: Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, white to off-white capsule shaped tablets, debossed with an Andrx logo with “571”on one side and “500” on the opposite side.
You can check the manufacturer of your medication, it is typically listed in fine print under the medication brand name with the prefix MFG or MFR. Anyone with an existing inventory of the product should quarantine the recalled lots immediately.Customers and patients with questions regarding this recall or wishing to return product may contact Inmar Pharmaceutical Services product recall processor to obtain instructions and a return kit for returning their medication:If you would like to report any adverse reactions or quality problems experienced with the use of this product you may contact Granules Drug Safety by phone at 1-877-7703183 Monday - Friday, 8:00 am EST to 8:00 pm EST, or via e-mail at Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.June 11, 2020 -- Lupin Pharmaceuticals Inc. is voluntarily recalling Metformin Hydrochloride Extended-Release Tablets USP, 500mg is a prescription oral medication indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. There’s no short-term risk, so stick with it until you talk to your doctor about alternative treatment options. Metformin is used to improve blood glucose control in adults with Type 2 diabetes mellitus.The recalled Metformin was sold in 500 mg dosages with a lot number of XP9004. A study from the Annals of Internal Medicine demonstrated that starting diabetes treatment with metformin is also linked with a lower long-term risk of:. Hence, Bayshore has decided to recall the two lots (Lot number 18641 and 18657).

Do not start, stop, or change the dose of any drug without checking with your doctor. Healthline Media does not provide medical advice, diagnosis, or treatment.